Market Closed -
Other stock markets
|
Pre-market 12:26:55 | |||
44.55 USD | -0.36% | 44.62 | +0.15% |
12:49pm | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
10:13am | Bristol-Myers Squibb Gets FDA Accelerated Approval for Breyanzi for Follicular Lymphoma | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.17% | 90.31B | |
+35.01% | 709B | |
+31.16% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.62% | 239B | |
+9.40% | 211B | |
-4.13% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60